InsiderTrades.com logo
An Unusual Way to Invest in Gold
From Edge On The Street   |   Ad
Most financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines.
See why this overlooked gold play

ATNF Insider Trading

Insider Ownership Percentage: 5.90%
Insider Buying (Last 12 Months): $65,420.54
Insider Selling (Last 12 Months): $0.00

180 Life Sciences Insider Trading History Chart

This chart shows the insider buying and selling history at 180 Life Sciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

180 Life Sciences Share Price & Price History

Current Price: $0.34
Price Change: ▲ Price Increase of +0.02 (6.31%)
As of 11/28/2023 01:00 AM ET

This chart shows the closing price history over time for ATNF up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
An Unusual Way to Invest in Gold
From Edge On The Street   |   Ad
Most financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines.
See why this overlooked gold play

180 Life Sciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/31/2023Donald A. McGovern, Jr.DirectorBuy10,000$1.15$11,500.0030,099View SEC Filing Icon  
5/18/2023James N. WoodyCEOBuy40,000$1.03$41,200.0041,888View SEC Filing Icon  
5/18/2023Ozan PamirCFOBuy5,162$1.01$5,213.628,983View SEC Filing Icon  
5/18/2023Pamela G MarroneDirectorBuy7,082$1.06$7,506.9212,469View SEC Filing Icon  
12/16/2021Quan Anh VuCOOBuy400$79.60$31,840.00View SEC Filing Icon  
12/10/2021Ozan PamirCFOBuy190$77.40$14,706.00View SEC Filing Icon  
12/10/2021Quan Anh VuCOOBuy225$78.00$17,550.00View SEC Filing Icon  
12/9/2021James N. WoodyCEOBuy625$85.40$53,375.00View SEC Filing Icon  
12/9/2021Donald A. McGovern, Jr.DirectorBuy1,250$82.60$103,250.00View SEC Filing Icon  
12/17/2020Marlene KraussMajor ShareholderSell825$49.60$40,920.0016,730View SEC Filing Icon  
12/14/2020Marlene KraussMajor ShareholderSell500$49.00$24,500.0016,730View SEC Filing Icon  
11/25/2020Marlene KraussMajor ShareholderSell609$55.60$33,860.40View SEC Filing Icon  
11/23/2020Marlene KraussMajor ShareholderSell3,031$65.20$197,621.20View SEC Filing Icon  
11/19/2020Marlene KraussMajor ShareholderSell1,672$42.40$70,892.80View SEC Filing Icon  
11/17/2020Marlene KraussMajor ShareholderSell165$45.20$7,458.00View SEC Filing Icon  
See Full Table
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for 180 Life Sciences (NASDAQ:ATNF)

4.07% of 180 Life Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ATNF by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

180 Life Sciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2023Armistice Capital LLC131,000$80K0.0%N/A2.462%Search for SEC Filing on Google Icon
11/8/2023Charles Schwab Investment Management Inc.348,908$0.21M0.0%N/A6.558%Search for SEC Filing on Google Icon
5/15/2023Cubist Systematic Strategies LLC23,521$42K0.0%N/A0.628%Search for SEC Filing on Google Icon
5/15/2023Two Sigma Investments LP14,071$25K0.0%N/A0.376%Search for SEC Filing on Google Icon
5/12/2023Renaissance Technologies LLC114,736$0.21M0.0%+404.6%3.062%Search for SEC Filing on Google Icon
2/15/2023Millennium Management LLC34,546$0.12M0.0%N/A1.710%Search for SEC Filing on Google Icon
2/14/2023Susquehanna International Group LLP20,829$71K0.0%+31.9%1.031%Search for SEC Filing on Google Icon
2/13/2023Renaissance Technologies LLC22,736$77K0.0%-81.7%1.126%Search for SEC Filing on Google Icon
2/13/2023Geode Capital Management LLC10,600$35K0.0%-95.0%0.525%Search for SEC Filing on Google Icon
11/14/2022Armistice Capital LLC3,915,000$2.60M0.0%N/A11.466%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC115,100$98K0.0%+138.7%0.337%Search for SEC Filing on Google Icon
5/16/2022State Street Corp73,587$0.19M0.0%+14.0%0.216%Search for SEC Filing on Google Icon
5/16/2022Engineers Gate Manager LP23,087$60K0.0%+63.7%0.068%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC48,213$0.13M0.0%N/A0.141%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.1,083,744$2.81M0.0%+7.9%3.179%Search for SEC Filing on Google Icon
2/10/2022Citizens Financial Group Inc RI131,775$0.51M0.0%N/A0.387%Search for SEC Filing on Google Icon
2/10/2022Rathbones Group PLC50,000$0.20M0.0%N/A0.147%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.240,813$1.30M0.0%-9.5%0.718%Search for SEC Filing on Google Icon
11/5/2021First National Trust Co19,000$0.10M0.0%N/A0.057%Search for SEC Filing on Google Icon
10/19/2021Belvedere Trading LLC51,544$0.31M0.0%-23.5%0.153%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC25,495$0.26M0.0%-13.2%0.076%Search for SEC Filing on Google Icon
9/7/2021Newbridge Financial Services Group Inc.3,000$30K0.0%N/A0.009%Search for SEC Filing on Google Icon
8/16/2021Pinz Capital Management LP12,100$0.12M0.0%+119.6%0.039%Search for SEC Filing on Google Icon
8/16/2021State Street Corp63,426$0.63M0.0%N/A0.206%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp29,068$0.29M0.0%+13.4%0.094%Search for SEC Filing on Google Icon
8/13/2021Murchinson Ltd.95,276$0.95M0.3%N/A0.310%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC123,049$1.23M0.0%-5.9%0.400%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.390,260$3.90M0.0%-22.2%1.268%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.266,016$2.66M0.0%+3.3%0.865%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC29,372$0.19M0.0%N/A0.163%Search for SEC Filing on Google Icon
5/17/2021HRT Financial LP17,590$0.12M0.0%N/A0.098%Search for SEC Filing on Google Icon
5/17/2021Pinz Capital Management LP5,510$36K0.0%N/A0.031%Search for SEC Filing on Google Icon
5/14/2021Credit Suisse AG10,300$68K0.0%N/A0.057%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC130,695$0.86M0.0%N/A0.725%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.257,396$1.69M0.0%N/A1.427%Search for SEC Filing on Google Icon
5/6/2021First National Trust Co12,000$79K0.0%N/A0.067%Search for SEC Filing on Google Icon
4/28/2021Mizuho Securities USA LLC52,400$0.34M0.0%N/A0.291%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
180 Life Sciences logo
180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed Phase IIb clinical trials that focuses on fibrosis and anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. 180 Life Sciences Corp. is headquartered in Palo Alto, California.
Read More on 180 Life Sciences

Today's Range

Now: $0.34
Low: $0.32
High: $0.36

50 Day Range

MA: $0.47
Low: $0.31
High: $0.71

52 Week Range

Now: $0.34
Low: $0.31
High: $9.00

Volume

1,999,310 shs

Average Volume

186,675 shs

Market Capitalization

$2.52 million

P/E Ratio

0.13

Dividend Yield

N/A

Beta

0.63

Who are the company insiders with the largest holdings of 180 Life Sciences?

180 Life Sciences' top insider investors include:
  1. James N Woody (CEO)
  2. Jr Donald A Mcgovern (Director)
  3. Pamela G Marrone (Director)
  4. Ozan Pamir (CFO)
  5. Quan Anh Vu (COO)
Learn More about top insider investors at 180 Life Sciences.

Who are the major institutional investors of 180 Life Sciences?

180 Life Sciences' top institutional shareholders include:
  1. Charles Schwab Investment Management Inc. — 6.56%
  2. Armistice Capital LLC — 2.46%
  3. Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of 180 Life Sciences stock.

Which institutional investors are buying 180 Life Sciences stock?

In the previous quarter, ATNF stock was bought by institutional investors including:
  1. Charles Schwab Investment Management Inc.
  2. Armistice Capital LLC
During the last year, these company insiders have bought 180 Life Sciences stock:
  1. James N Woody (CEO)
  2. Jr Donald A Mcgovern (Director)
  3. Pamela G Marrone (Director)
  4. Ozan Pamir (CFO)
  5. Quan Anh Vu (COO)
Learn More investors buying 180 Life Sciences stock.
An Unusual Way to Invest in Gold
From Edge On The Street   |   Ad
Most financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines.
See why this overlooked gold play